NICE to develop neuropad® guidance

The NICE (National Institute for Health and Care Excellence) logo, alongside a neuropad screening test

Following a comprehensive initial submission and review process during 2016, culminating on the 23rd of December 2016 with a decision by the National Institute of Health and Care Excellence (NICE) Medical Technologies Advisory Committee (MTAP, the committee decided to develop new guidance for the neuropad® 10-Minute Screening Test for the early detection of diabetic neuropathy.
For those that may be unfamiliar with NICE and the Medical Technologies Evaluation Programme (MTEP), the MTEP was launched in November 2009 and represents an enhancement in capacity for the evaluation of devices and diagnostic technologies. The programme is designed to help the NHS in England adopt efficient and cost-effective medical devices and diagnostics more rapidly and consistently. The Medical Technologies Advisory Committee (MTAC) supports the MTEP. It has two main functions:

  1. The selection of innovative medical technologies and routing of these to the appropriate NICE guidance producing programme.
  2. The development of its own recommendations which are issued as Medical Technology Guidance. It is this process that neuropad® is undergoing currently.

The Medical Technologies Evaluation Programme sits within the Centre for Health Technology Evaluation at NICE, and it both complements and operates in conjunction with NICE’s existing guidance producing programmes.

Regarding the development of NICE MTEP guidance on neuropad®, interested parties may register as stakeholders by visiting the relevant page on the NICE web site.